Summary:

This white paper describes how one global pharmaceutical manufacturer successfully implemented the world’s first fully digital and patient-centric drug safety program to increase market penetration, accelerate therapy adoption, improve adherence and decrease prescription abandonment.

By tying multiple stakeholders into a single digital ecosystem, physicians can now seamlessly guide patients through the required REMS (Risk Evaluation and Mitigation Strategy)  process with real-time data and insights. Keep reading to learn how Medocity:

• Created a breakthrough patient-centric digital REMS program to increase market penetration, accelerate therapy adoption, improve adherence and decrease prescription abandonment
• Navigated the necessary cross-functional collaboration to ensure commercial
  success
• Effectively implemented and executed a digital patient support program to improve the patient and provider experience and increase engagement

Download the entire white paper today!